This is a short excerpt from our full conversation with Celine Halioua, Founder & CEO of Loyal, which recently raised a $100M Series C, and Village Global GP Sam Kirschner.
Celine discusses Loyal's 10-year vision for expanding into cats and humans, why the pharmaceutical industry has been slow to treat aging as a drug category, and why the biological and economic case for going dogs-first is stronger than most people realize.
Listen to the full episode here:
https://www.villageglobal.com/podcastThanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at
www.villageglobal.com or get in touch with us on X @villageglobal.
Want to get updates from us? Subscribe to get a peek inside the Village. We'll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley.
www.villageglobal.com/signup
